Bio-Rad Laboratories, Inc. (BIO) financial statements (2021 and earlier)

Company profile

Business Address 1000 ALFRED NOBEL DRIVE
HERCULES, CA 94547
State of Incorp. DE
Fiscal Year End December 31
SIC 3826 - Laboratory Analytical Instruments (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments9911,115845755839786698
Cash and cash equivalents662661432384456458413
Short-term investments329454413371383329284
Restricted cash and investments666654 
Receivables419393392465372391378
Inventory, net of allowances, customer advances and progress billings622554584595525490471
Inventory622554584595525490471
Prepaid expense911021871469194108
Other current assets11111010121162
Total current assets:2,1402,1802,0231,9771,8451,7781,716
Noncurrent Assets
Operating lease, right-of-use asset202202
Property, plant and equipment491499509493489438429
Long-term investments and receivables9,5614,6382,6561,028831720389
Long-term investments9,5614,6382,6561,028831720389
Intangible assets, net (including goodwill)491410353680639710755
Goodwill292264220506477496500
Intangible assets, net (excluding goodwill)199146133174162214254
Other noncurrent assets87807095   
Other undisclosed noncurrent assets    486652
Total noncurrent assets:10,8335,8293,5882,2962,0061,9341,625
TOTAL ASSETS:12,9738,0095,6114,2733,8513,7123,341
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities420315295347325310317
Accounts payable139107122135133122129
Employee-related liabilities223180144172163158153
Taxes payable57282940282935
Deferred revenue4234
Debt446200000
Deferred revenue and credits28313027
Other liabilities13187101127115102103
Other undisclosed current liabilities34954    
Total current liabilities:632905451503471441447
Noncurrent Liabilities
Long-term debt and lease obligation, including:1214439435434436436
Finance lease, liability1111
Operating lease, liability175176
Other undisclosed long-term debt and lease obligation(174)(174)439435434436436
Liabilities, other than long-term debt2,369241701405358344274
Deferred tax liabilities, net553222223233155
Deferred income tax liabilities2,077 
Liability, pension and other postretirement and postemployment benefits9580     
Other liabilities197161148183135111119
Other undisclosed noncurrent liabilities801,093     
Total noncurrent liabilities:2,4611,3481,140840792780709
Total liabilities:3,0932,2541,5911,3431,2641,2211,156
Stockholders' equity
Stockholders' equity attributable to parent, including:9,8805,7554,0202,9302,5872,4912,185
Additional paid in capital429410394361333300271
Accumulated other comprehensive income (loss)282(87)(47)739418382219
Retained earnings9,2685,4713,7221,8301,8361,8081,695
Other undisclosed stockholders' equity attributable to parent(100)(38)(49)(0)(0)(0)(0)
Total stockholders' equity:9,8805,7554,0202,9302,5872,4912,185
TOTAL LIABILITIES AND EQUITY:12,9738,0095,6114,2733,8513,7123,341

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues2,5462,3122,2892,1602,0682,0192,175
Revenue, net2,1602,0682,0192,175
Cost of revenue
(Cost of Goods and Services Sold)
(1,108)(1,055)(1,066)(973)(930)(898)(997)
Other undisclosed gross profit0(0)0   0
Gross profit:1,4381,2571,2231,1871,1381,1221,179
Operating expenses(1,027)(1,027)(1,326)(1,071)(1,085)(955)(1,103)
Other undisclosed operating income      75
Operating income (loss):411230(103)11753167150
Nonoperating income232434310117
Investment income, nonoperating      13
Foreign currency transaction loss, before tax(2)(2)(3)(9)(5)(10)(9)
Other nonoperating income24263712151113
Interest and debt expense(22)(23)(24)(22)(22)(22)(22)
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes4,4962,031606   (13)
Income from continuing operations before income taxes:4,9082,2615139842146132
Income tax expense (benefit)(1,101)(502)(147)24(13)(33)(43)
Net income available to common stockholders, diluted:3,8061,7593661222811389

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net income:3,8061,7593661222811389
Other comprehensive income (loss)370(40)(106)32136163(122)
Comprehensive income (loss), net of tax, attributable to parent:4,1761,71825944364276(33)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: